No insider purchase over the last 90 days. The latest, by 袁征, was filed 21 Jan 2025.
Shanghai Kinetic Medical Co., Ltd: what insiders have been doing
Shanghai Kinetic Medical Co., Ltd has a thin disclosure history in our data (latest filing: 21 January 2025). New filings will appear here as soon as they are published. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Top signal score 15 of 100
Buys €2Mn/a Sells
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 8,779 of 23,476 companies
57.8
score / 100
Value
43
Quality
73
FCF yld2.8%
Earn yld3.0%
EV/EBITDA20.4x
ROE7.5%
Gross mgn54%
Net mgn14%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
2,306,900 shares100.0% of flowA股XSHESZSE:173000008473314750
Canonical exit: 21 Apr 2025 (T+90)
1 of 1 declaration
About Shanghai Kinetic Medical Co., Ltd
ST凯利 is a company operating in the healthcare and pharmaceutical sector, listed on the XSHE market. It focuses on the development and distribution of pharmaceutical products.